Tuesday, 3 November 2026
M
Meridian Globe
Live briefing
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Camarines Norte communities take charge of local climate fight— Rappler 菲律宾拉普勒St. Luke’s, NPC investigating data breach on mobile app— Rappler 菲律宾拉普勒Merz says next German president should be a woman— The Local Germany 德国本地Anthropic seeks to raise up to $3.5bn from Japanese investors in IPO— 日经 Nikkei AsiaJapan can build defense edge on AI, Palantir CEO says— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Camarines Norte communities take charge of local climate fight— Rappler 菲律宾拉普勒St. Luke’s, NPC investigating data breach on mobile app— Rappler 菲律宾拉普勒Merz says next German president should be a woman— The Local Germany 德国本地Anthropic seeks to raise up to $3.5bn from Japanese investors in IPO— 日经 Nikkei AsiaJapan can build defense edge on AI, Palantir CEO says— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei Asia

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Source Science 科学1d ago
Summary

Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Americas
Language
English
Item ID
science-03c8fc81

Comments 0 comments

No comments yet. Be the first.

U.S. approval of cheap, generic HIV prevention shot may boost global rollout · Meridian Globe